Mechanisms of IVIG Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy

被引:0
|
作者
Björn Tackenberg
Falk Nimmerjahn
Jan D. Lünemann
机构
[1] Philipps-University,Clinical Neuroimmunology Group, Department of Neurology
[2] University of Erlangen-Nuremberg,Institute of Genetics, Department of Biology
[3] University Hospital Zurich,Institute for Experimental Immunology, Clinical Immunology and Immunotherapy
来源
关键词
Chronic inflammatory demyelinating polyneuropathy; CIDP; intravenous immunoglobulin; IVIG;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:65 / 69
页数:4
相关论文
共 50 条
  • [1] Mechanisms of IVIG Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy
    Tackenberg, Bjoern
    Nimmerjahn, Falk
    Luenemann, Jan D.
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2010, 30 : S65 - S69
  • [2] ALEMTUZUMAB IN THE TREATMENT OF IVIG-DEPENDENT CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
    Marsh, E. A.
    Llewellyn, J. G.
    Reilly, M. M.
    Krishnan, A.
    Doran, M.
    Ryan, A. M.
    Coles, A. J.
    Robertson, N. P.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (11):
  • [3] Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy
    E. A. Marsh
    C. L. Hirst
    J. G. Llewelyn
    M. D. Cossburn
    M. M. Reilly
    A. Krishnan
    M. Doran
    A. M. Ryan
    A. J. Coles
    J. L. Jones
    N. P. Robertson
    [J]. Journal of Neurology, 2010, 257 : 913 - 919
  • [4] Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy
    Marsh, E. A.
    Hirst, C. L.
    Llewelyn, J. G.
    Cossburn, M. D.
    Reilly, M. M.
    Krishnan, A.
    Doran, M.
    Ryan, A. M.
    Coles, A. J.
    Jones, J. L.
    Robertson, N. P.
    [J]. JOURNAL OF NEUROLOGY, 2010, 257 (06) : 913 - 919
  • [5] ALEMTUZUMAB IN THE TREATMENT OF IVIg-DEPENDENT CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
    Llewelyn, J. G.
    Reilly, M. M.
    Krishnan, A., V
    Doran, M.
    Ryan, A.
    Robertson, N. P.
    [J]. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2009, 14 : 90 - 91
  • [6] EFFICACY AND SAFETY OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) IGPRO10 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)
    Sabet, Arman
    Mielke, Orell
    van Schaik, Ivo N.
    Leger, Jean-Marc
    Bril, Vera
    van Gloven, Nan
    Hartung, Hans Peter
    Lewis, Richard A.
    Sobue, Gen
    Lawo, John-Philip
    Durn, Billie L.
    Cornblath, David R.
    De Bleecker, Jan L.
    Sommer, Claudia
    Robberecht, Wim
    Saarela, Mika
    Kamienowski, Jerzy
    Stelmasiak, Zbigniew
    Tackenberg, Bjorn
    Merkies, Ingemar S. J.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E19 - E19
  • [7] Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy
    Cornblath, David R.
    van Doorn, Pieter A.
    Hartung, Hans-Peter
    Merkies, Ingemar S. J.
    Katzberg, Hans D.
    Hinterberger, Doris
    Clodi, Elisabeth
    [J]. BRAIN, 2022, 145 (03) : 887 - 896
  • [8] IVIG regulates BAFF expression in patients with chronic inflammatory demyelinating polyneuropathy (CIDP)
    Ritter, Christian
    Foerster, Dominik
    Albrecht, Philipp
    Hartung, Hans-Peter
    Kieseier, Bernd C.
    Lehmann, Helmar C.
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2014, 274 (1-2) : 225 - 229
  • [9] THE PROCID STUDY: EFFICACY AND SAFETY OF 3 DIFFERENT DOSAGES OF IVIG (PANZYGA®) IN PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
    Cornblath, David
    Van Doorn, Pieter
    Hartung, Hans Peter
    Merkies, Ingemar
    Katzberg, Hans
    Hinterberger, Doris
    Clodi, Elisabeth
    [J]. MUSCLE & NERVE, 2020, 62 : S3 - S3
  • [10] CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
    RIZZUTO, N
    SIMONATI, A
    [J]. INTERNATIONAL JOURNAL OF TISSUE REACTIONS-EXPERIMENTAL AND CLINICAL ASPECTS, 1985, 7 (06): : 521 - 526